共 50 条
- [1] METHOTREXATE, VINBLASTINE, EPIDOXORUBICIN, AND BLEOMYCIN AS 2ND-LINE CHEMOTHERAPY FOR RECURRENT AND/OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J]. ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 1994, 56 (05): : 279 - 282
- [2] IMMUNOMODULATION THERAPY FOR SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1993, 15 (03): : 266 - 270
- [3] SQUAMOUS-CELL CARCINOMA RADIOIMMUNOASSAY IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J]. AMERICAN JOURNAL OF SURGERY, 1989, 157 (05): : 503 - 504
- [7] MULTIMODALITY THERAPY FOR UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (05): : 380 - 383
- [10] 2ND PRIMARY TUMORS IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA [J]. CANCER, 1995, 75 (06) : 1343 - 1353